SCHEMBL6174418

SCHEMBL6174418

COc1ccc(Nc2cc(CN3C(=O)N(c4ccccc4SC(F)(F)F)C(=O)C3(C)C)ccn2)cn1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 19/20 0.60
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2935176 0.87 IGF1R (0.75) IGF1R
SCHEMBL2941516 0.81 IGF1R (0.70) IGF1R
SCHEMBL6221882 0.80 IGF1R (0.58) IGF1R
SCHEMBL2935582 0.76 IGF1R (0.79) IGF1R
SCHEMBL2980303 0.76 IGF1R (0.82) IGF1R
SCHEMBL2996026 0.76 IGF1R (0.81) IGF1R
SCHEMBL3734038 0.76 IGF1R (0.72) IGF1R
SCHEMBL4101203 0.76 IGF1R (0.78) IGF1R
SCHEMBL4033708 0.76 IGF1R (0.78) IGF1R
SCHEMBL2939085 0.76 IGF1R (1.00) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP claimed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO claimed